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Cells in early stages of chromosome condensation
are very vulnerable, and many stresses that do not
damage DNA induce a transient return to late G2
phase. Such stresses include the drug-induced dis-
assembly of microtubules, which triggers an ATM-
independent G2 checkpoint pathway involving a
novel ubiquitin ligase.
Checkpoint controls are biochemical pathways that
slow or retard cell cycle progression in response 
to stress, damage or incomplete activities [1]. They are
not essential for the workings of the cell cycle, but they
exist to ensure genomic stability [2]. At a minimum, each
checkpoint consists of three components [3]. The first is
a monitoring system, which senses if a particular event
being ‘checked’ is completed and/or disrupted. This
monitor then uses a signal transduction pathway to relay
information on the status of the event to the cell cycle
machinery. Finally, this pathway targets one or more
components in the machinery to transiently impede or
break cell-cycle progression. Checkpoint pathways are
present during all stages of the cell cycle, including
mitosis. Here we shall focus on recent evidence that,
invertebrates, microtubules are involved in a checkpoint
that regulates progression of late G2 cells into mitosis.
By far the best understood G2 checkpoints are those
that prevent entry into mitosis in response to DNA
damage (reviewed in [4]). When triggered, these com-
plementary and interfaced pathways use a monitoring
system, centered around the ATM/ATR kinase, to
ultimately prevent activation of the master mitotic reg-
ulator, cyclin B–Cdk1. In one of these routes, ATM
directly (or indirectly) activates the p53 pathway,
which inhibits entry into mitosis by inducing the
synthesis of cyclin-dependent kinase (Cdk) inhibitors,
such as p21. In another route, independent of p53,
ATM activates the Chk1 and Chk2 kinases, which in
turn prevent activation of the Cdc25C phosphatase
via, in some cases, the polo-like kinase Plk1. Cdc25C
is required for the ultimate activation of cyclin B–Cdk1.
Many Stresses Delay Progression Through Late G2
The G2/M transition is, however, notoriously sensitive
to a wide variety of insults, many of which do not
directly damage DNA. For example, when cells in early
prophase are subjected to various drugs, hypother-
mia, anoxia, osmotic shock or other stresses, they
decondense their chromosomes and return to late G2
(reviewed in [5]). For the most part, this reaction is
reversible, and mitotic progression is re-initiated after
an adaptation period or when the stress is alleviated.
In these examples, the cell cycle is transiently halted
near the end of G2 at a point known as ‘antephase’
(reviewed in [5]). It is significant that these same
agents cannot stop progression into mitosis when
applied after the cell has passed a critical juncture,
which in vertebrates occurs during late prophase as
cyclin B–Cdk1 starts to accumulate in the nucleus [6].
The stress-induced reversion of chromosome
condensation thus occurs before the explosive
activation of cyclin B–Cdk1 which commits the cell to
mitosis. This implies that the targets of the reversion
pathway are upstream from cyclin B–Cdk1 activation,
and that the activity of these targets is ultimately
required for entry into mitosis. Such targets likely
include, in part, other kinases that are involved in
preparing the nucleus (cyclin A–Cdk2 [7] or aurora B
[8], for example) and cytoplasm (Plk1 [9,10], for
example) for mitosis.
Does the delay in antephase progression, induced by
various stressful stimuli, result from triggering the DNA
damage checkpoint — for example through oxidative
stress, which is thought to be the primary source of
DNA breaks in mammals [4]? The current evidence
suggest that the answer to this question is no.
A Late G2 Checkpoint Not Involving DNA Damage
When microtubules are suddenly disassembled by
nocodazole or colcemid in early prophase, many
types of cultured cell return to antephase for 2–4
hours before ultimately entering mitosis in the pres-
ence of the drug [11]. This transient delay in
antephase induces a ‘lag’ period of several hours
during which the mitotic index does not increase after
microtubules are disassembled. The presence of this
lag reveals that cells already in antephase when the
drug was added are also retarded in entering mitosis. 
This delay is not seen when microtubules are stabi-
lized by taxol, or when actin filaments are
depolymerized by cytochalasin D. Interestingly, a
similar delay in entering mitosis has been reported
after microtubules were disassembled with colcemid,
but not nocodazole, in a variety of normal human  cell
lines, but not those derived from tumors [12]. As this
delay occurs in cells lacking ATM (such as the ataxia-
telangiectasia homozygote cell line GM3395 [12]) or
p53 (such as U20S cells), and as the delay is not
prevented by caffeine treatment [11], it is not the result
of triggering the DNA damage checkpoint pathways.
In the absence of p53, a transcription factor, cells
progress through G1 and S phases in the presence of
damaged DNA. But the addition of a functional copy
of p53 to mutants lacking the protein restores this
checkpoint. This relief-of-dependence is a character-
istic feature of a checkpoint control [13]. The lag in the
mitotic index seen in normal, but not transformed,
cells when microtubules are disassembled suggests
that conditions — mutants — can be defined in which
timely progression into mitosis no longer depends on
the integrity of microtubules.
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It now appears that this is, indeed, the case. A
search of the ‘expressed-sequence tag’ (EST) data-
base for domains present in proteins involved in cell
cycle transitions led Scolnick and Halazonetis [14] to
identify the Chfr protein (checkpoint protein with FHA
and ring finger domains). Actively growing human cells
producing Chfr are delayed in entering mitosis for 2–3
hours when their microtubules are disassembled by
colcemid or nocodazole. But cells lacking functional
Chfr — including lines derived from many tumors —
exhibit no such delay in entering mitosis after micro-
tubule disassembly. That the Chfr protein is part of a
checkpoint pathway is strongly supported by the
observation that ectopic expression of wild-type Chfr
in tumor cells lacking the protein restores the cell-
cycle delay.
What is Chfr and how does it function in the
antephase checkpoint? Surprisingly Kang et al. [9]
have recently shown that Chfr is a novel ubiquitin
ligase which promotes the formation of high molecu-
lar weight ubiquitin conjugates in vitro and in vivo.
Ubiquitination is a key step in targeting a protein for
subsequent destruction by proteolysis. When made in
Xenopus extracts, Chfr retards activation of the cyclin
B–Cdk1 kinase, and thus entry into mitosis, by pre-
venting the dephosphorylation of tyrosine 15 on Cdk1.
It appears to accomplish this task by targeting Plk1
for destruction. In the absence of Plk1, activation of
the Cdc25C phosphatase is delayed and the Wee1
kinase is allowed to maintain its inhibitory phosphory-
lation of Cdk1. As cells lacking Chfr appear to undergo
a normal G2/M transition in the absence of drug treat-
ment, and as there is not normally a requirement for
ubiquitin-mediated proteolysis during the G2/M tran-
sition, Kang et al. [9] conclude that Chfr is required
only for a checkpoint pathway that retards entry into
mitosis in the presence of mitotic stress.
What Does the Chfr Checkpoint Monitor?
Many questions regarding how the pathway works
remain to be resolved. Scolnick and Halazonetis [14]
suggested that the checkpoint monitors centrosome
separation, prolonging G2 (antephase) in the absence
of this event. The earlier observation that Plk1 is required
for centrosome maturation, which normally occurs
near the time the cell becomes committed to mitosis,
lends credence to this idea [15], as do recent findings
that centrosomes are required for the G1/S transition
[16,17]. Moreover, even though many cells in culture
enter mitosis with non-separated centrosomes, which
induces the transient formation of a monopolar
spindle, it is possible that these are retarded in pro-
gression through antephase. Fortunately, in many cul-
tured cells the separation of centrosomes is frequently
completed prior to chromosome condensation [18,19].
In view of this, the idea that the Chfr-mediated check-
point monitors centrosome separation can be tested
by simply adding nocodazole to γ-tubulin–GFP pro-
ducing cells entering prophase in the presence of
well-separated centrosomes. Another possibility
would be to determine whether drugs that specifically
inhibit centrosome separation, such as monastrol [20],
prolong G2.
Jha et al. [12] and Rieder and Cole [11] found that
the pathway prolonging antephase is not activated 
by taxol, which stabilizes microtubules (and also
inhibits centrosome separation), whereas Scolnick
and Halazonetis [14] report that it is. So it remains
unclear whether the pathway is triggered by lack 
of microtubule function, or some other aspect of
microtubule activity. Kang et al. [9] conclude that
“once mitotic stress is relieved and defects are
repaired, the Chfr ligase is inactivated and de novo
synthesis of Plk1 drives cells into mitosis”. But live 
cell analyses show that the checkpoint is extremely
leaky, and several hours after microtubule disassem-
bly the cells progress into, and become delayed 
in, mitosis — even in the continued absence of 
microtubules. So it is possible that Chfr is activated 
in response to the sudden destruction of micro-
tubules, which may disrupt a number of microtubule-
mediated events, including the transport, localization
and scaffolding of signaling molecules, all of which 
are likely important in preparing the cell for mitosis. 
It will be important to assess how early prophase 
cells respond to nanomolar concentrations of noco-
dazole and taxol, which disturb microtubule dynamics
without changing the amount of tubulin polymer.
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Figure 1. Selected frames (A–F) from a
timelapse sequence showing a mid-
prophase PtK1 cell after a sudden
exposure to nocodazole.
In response to this insult, the cell tran-
siently decondensed its chromosomes
(A–C). Several (5) hours later, the cell re-
entered prophase in the presence of 
the drug and became arrested by the
spindle assembly checkpoint in a ‘C-
prometaphase’ state. Time in minutes
after nocodazole addition is shown in the
lower left corner. Bar (F): 10 µm.
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Finally, it is possible that Chfr activation is part of a
general stress response. In this regard, it remains to
be determined whether other insults that prolong
antephase also trigger the Chfr pathway. Attractive
arguments can be made that progression through G2
is also regulated by stress-activated kinase pathways
that are triggered in response to a wide range of
changes in intra- and intercellular conditions. These
pathways, based on the p38 and JNK kinases, also
ultimately modulate cyclin B–Cdk1 activity [4].
Whether inhibiting the activity of stress-activated
protein kinases modulates the Chfr pathway remains
to be determined. Challenges for the future including
determining how the Chfr checkpoint pathway is trig-
gered, identifying its additional molecular con-
stituents, and understanding how it interfaces with
other stress-induced kinase pathways that delay cell-
cycle progression.
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Figure 2. A suggested mechanism for the late G2 (antephase)
delay induced by the Chfr-based pathway (yellow box).
Disruption of microtubules activates the ubiquitin ligase Chfr,
which induces the degradation of Plk1. The resulting imbalance
in the activities of the inhibitory Wee1 kinase and the activating
Cdc25C phosphatase prolongs the inhibitory phosphorylation
of Cdk1 on Tyr 15. In the absence of Cdk1 dephosphorylation
by Cdc25C (right side), and also the direct phosphorylation of
cyclin B by Plk1 (middle), the accumulation of cyclin B–Cdk1 in
the nucleus is prevented and entry into mitosis is stalled. Other
late G2 pathways may also exist that retard entry into mitosis
in response to disrupting microtubule function. Stress-induced
kinase pathways involving, for example, p38, can prevent acti-
vation of cyclin B–Cdk1 either directly or indirectly by inhibiting
the cyclin A–Cdk2. Disassembling microtubules also disrupts
normal intracellular transport and releases microtubule-associ-
ated proteins, such as PP2A phosphatases, throughout the
cytoplasm. The latter may lead to the dephosphorylation of
proteins such as Cdc25C which are normally phosphorylated,
and thus inhibited, by Plk1. Kinases are shown in red and phos-
phatases in blue.
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